Fred Hutch at ASH: Expanding CAR-T access, AML treatment strategies, climate and cancer — and ASH lifetime achievement award
SEATTLE — Dec. 2, 2025 — Fred Hutch Cancer Center experts will present the latest findings in blood…
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis
Bhutani M, Foureau DM, Atrash S, Voorhees PM, Usmani SZ. Extramedullary multiple myeloma. Leukemia. 2020;34:1–20. Article PubMed Google…
Phase 3 Trial Confirms Sarilumab Improves Polymyalgia Rheumatica Outcomes
Vibeke Strand, MD Credit: PRIME Education New phase 3 data supported the effectiveness of sarilumab 200 mg every…